Literature DB >> 18802063

T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.

Joseph Barbi1, Frank Brombacher, Abhay R Satoskar.   

Abstract

Genetic background influences the outcome of Leishmania major infection. C57BL/6 mice mount a Th1 response and resolve infection. In contrast, BALB/c mice mount a Th2 response and develop chronic lesions. This susceptible phenotype is seen even though BALB/c mice generate IFN-gamma-producing T cells at proportions similar to C57BL/6 mice in their lymph nodes (LN) early after infection. We had previously shown that chemokine receptor CXCR3 mediates immunity against L. major by recruiting IFN-gamma-producing T cells to the lesions of C57BL/6 mice. Therefore, we hypothesized that IFN-gamma-secreting T cells in BALB/c mice are unable to confer protection because they may be defective in up-regulating CXCR3. To test this hypothesis, we analyzed kinetics of CXCR3-expressing T cells in the LN and lesions of BALB/c and C57BL/6 mice during L. major infection. Additionally, we compared the ability of T cells from BALB/c and C57BL/6 mice to up-regulate CXCR3 upon activation. We found that resolution of L. major infection in C57BL/6 mice was associated with an increase in the proportion of CXCR3(+) T cells in regional LN and lesions, whereas disease progression in BALB/c mice was associated with a decrease in these populations. Anti-CD3/CD28-activated T cells from naive BALB/c but not C57BL/6 mice were defective in up-regulating CXCR3. Impaired induction of CXCR3 on BALB/c T cells was not due to lack of IFN-gamma and was mediated partially by IL-10 but not IL-4 or IL-13. We propose that defective CXCR3 up-regulation on T cells in BALB/c mice may contribute to L. major susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802063      PMCID: PMC2562238          DOI: 10.4049/jimmunol.181.7.4613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Viral IL-10 gene transfer inhibits the expression of multiple chemokine and chemokine receptor genes induced by inflammatory or adaptive immune stimuli.

Authors:  Dongmei Chen; Yaozhong Ding; Nan Zhang; Bernd Schröppel; Shuang Fu; Weiping Zang; Haojiang Zhang; Wayne W Hancock; Jonathan S Bromberg
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

2.  Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation.

Authors:  Chigusa Nakajima; Takao Mukai; Nobuya Yamaguchi; Yasunari Morimoto; Woong-Ryeon Park; Masayuki Iwasaki; Ping Gao; Shiro Ono; Hiromi Fujiwara; Toshiyuki Hamaoka
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

3.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Coexistence of antigen-specific TH1 and TH2 cells in genetically susceptible BALB/c mice infected with Leishmania major.

Authors:  M Lohoff; F Sommer; W Solbach; M Röllinghoff
Journal:  Immunobiology       Date:  1989-10       Impact factor: 3.144

5.  IL-4 exacerbates disease in a Th1 cell transfer model of colitis.

Authors:  M Fort; R Lesley; N Davidson; S Menon; F Brombacher; M Leach; D Rennick
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

Review 6.  Susceptibility to Leishmania major infection in the absence of IL-4.

Authors:  N Noben-Trauth
Journal:  Immunol Lett       Date:  2000-12-01       Impact factor: 3.685

7.  CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.

Authors:  T Jinquan; C Jing; H H Jacobi; C M Reimert; A Millner; S Quan; J B Hansen; S Dissing; H J Malling; P S Skov; L K Poulsen
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

8.  IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.

Authors:  C Albanesi; C Scarponi; S Sebastiani; A Cavani; M Federici; O De Pità; P Puddu; G Girolomoni
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

9.  Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection.

Authors:  M Mohrs; C Holscher; F Brombacher
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

10.  Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes.

Authors:  Hiroyuki Yoneyama; Shosaku Narumi; Yanyun Zhang; Masako Murai; Marco Baggiolini; Antonio Lanzavecchia; Takafumi Ichida; Hitoshi Asakura; Kouji Matsushima
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

View more
  12 in total

1.  Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Authors:  Steve Oghumu; James C Stock; Sanjay Varikuti; Ran Dong; Cesar Terrazas; Jessica A Edwards; Chad A Rappleye; Ariel Holovatyk; Arlene Sharpe; Abhay R Satoskar
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 2.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

3.  Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.

Authors:  Jonathan W Willett; Julien Herrou; Daniel M Czyz; Jason X Cheng; Sean Crosson
Journal:  Vaccine       Date:  2016-08-31       Impact factor: 3.641

4.  CXCL10 production by human monocytes in response to Leishmania braziliensis infection.

Authors:  Diego A Vargas-Inchaustegui; Alison E Hogg; Gianfranco Tulliano; Alejandro Llanos-Cuentas; Jorge Arevalo; Janice J Endsley; Lynn Soong
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

5.  Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.

Authors:  Sanjay Varikuti; Gayathri Natarajan; Steve Oghumu; Rachel H Sperling; Ellen Moretti; James Stock; Tracey L Papenfuss; Abhay R Satoskar
Journal:  Cell Immunol       Date:  2016-09-06       Impact factor: 4.868

6.  The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells.

Authors:  Sara Shokooh Saremi; Maryam Shahryari; Razieh Ghoorchian; Hamed Eshaghian; Seyed Amir Jalali; Amin Reza Nikpoor; Mahmoud Reza Jafari; Ali Badiee
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

7.  Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.

Authors:  Raju Sunagar; Sudeep Kumar; Prachi Namjoshi; Sarah J Rosa; Karsten R O Hazlett; Edmund J Gosselin
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

8.  T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

Authors:  James Alexander; Frank Brombacher
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

9.  B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections.

Authors:  Trupti Joshi; Susana Rodriguez; Vladimir Perovic; Ian A Cockburn; Simona Stäger
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

10.  Tularemia vaccine development: paralysis or progress?

Authors:  Raju Sunagar; Sudeep Kumar; Brian J Franz; Edmund J Gosselin
Journal:  Vaccine (Auckl)       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.